395 related articles for article (PubMed ID: 27490411)
61. Awarding additional MELD points to the shortest waitlist candidates improves sex disparity in access to liver transplant in the United States.
Bernards S; Lee E; Leung N; Akan M; Gan K; Zhao H; Sarkar M; Tayur S; Mehta N
Am J Transplant; 2022 Dec; 22(12):2912-2920. PubMed ID: 35871752
[TBL] [Abstract][Full Text] [Related]
62. Liver transplant recipient selection: MELD vs. clinical judgment.
Fink MA; Angus PW; Gow PJ; Berry SR; Wang BZ; Muralidharan V; Christophi C; Jones RM
Liver Transpl; 2005 Jun; 11(6):621-6. PubMed ID: 15915491
[TBL] [Abstract][Full Text] [Related]
63. A Share 21 model in liver transplantation: Impact on waitlist outcomes.
Nagai S; Chau LC; Kitajima T; Yeddula S; Collins K; Rizzari M; Yoshida A; Abouljoud MS; Moonka D
Am J Transplant; 2020 Aug; 20(8):2184-2197. PubMed ID: 32155314
[TBL] [Abstract][Full Text] [Related]
64. Risk Factors for High Mortality on the Liver Transplant Waiting List in Times of Organ Shortage: A Single-Center Analysis.
Husen P; Hornung J; Benko T; Klein C; Willuweit K; Buechter M; Saner FH; Paul A; Treckmann JW; Hoyer DP
Ann Transplant; 2019 May; 24():242-251. PubMed ID: 31048668
[TBL] [Abstract][Full Text] [Related]
65. OPTN/SRTR 2019 Annual Data Report: Liver.
Kwong AJ; Kim WR; Lake JR; Smith JM; Schladt DP; Skeans MA; Noreen SM; Foutz J; Booker SE; Cafarella M; Snyder JJ; Israni AK; Kasiske BL
Am J Transplant; 2021 Feb; 21 Suppl 2():208-315. PubMed ID: 33595192
[TBL] [Abstract][Full Text] [Related]
66. Effect of recipient age on prioritisation for liver transplantation in the UK: a population-based modelling study.
Attia A; Webb J; Connor K; Johnston CJC; Williams M; Gordon-Walker T; Rowe IA; Harrison EM; Stutchfield BM
Lancet Healthy Longev; 2024 May; 5(5):e346-e355. PubMed ID: 38705152
[TBL] [Abstract][Full Text] [Related]
67. Update on the management of the liver transplant patient.
Kwong AJ; Fix OK
Curr Opin Gastroenterol; 2015 May; 31(3):224-32. PubMed ID: 25774445
[TBL] [Abstract][Full Text] [Related]
68. Reduced Access to Liver Transplantation in Women: Role of Height, MELD Exception Scores, and Renal Function Underestimation.
Allen AM; Heimbach JK; Larson JJ; Mara KC; Kim WR; Kamath PS; Therneau TM
Transplantation; 2018 Oct; 102(10):1710-1716. PubMed ID: 29620614
[TBL] [Abstract][Full Text] [Related]
69. Competition in liver transplantation: helpful or harmful?
Saidi RF; Razavi M; Cosimi AB; Ko DS
Liver Transpl; 2015 Feb; 21(2):145-50. PubMed ID: 25370903
[TBL] [Abstract][Full Text] [Related]
70. Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.
Rahimi-Dehkordi N; Nourijelyani K; Nasiri-Tousi M; Ghodssi-Ghassemabadi R; Azmoudeh-Ardalan F; Nedjat S
Arch Iran Med; 2014 Feb; 17(2):118-21. PubMed ID: 24527973
[TBL] [Abstract][Full Text] [Related]
71. Combined heart-liver transplantation in the MELD era: do waitlisted patients require exception status?
Schaffer JM; Chiu P; Singh SK; Oyer PE; Reitz BA; Mallidi HR
Am J Transplant; 2014 Mar; 14(3):647-59. PubMed ID: 24517245
[TBL] [Abstract][Full Text] [Related]
72. Exception Policy Change Increased the Simultaneous Kidney-Liver Transplant Probability of Polycystic Disease in the Centers With High Median MELD at Transplantation.
Miyake K; Kim DY; Chau LC; Trudeau S; Kitajima T; Wickramaratne N; Shimada S; Nassar A; Yoshida A; Abouljoud MS; Nagai S
Transplantation; 2024 Jul; 108(7):1632-1640. PubMed ID: 38548699
[TBL] [Abstract][Full Text] [Related]
73. An Outcome-Based Approach to Assign MELD Exception Points for Patients With Hepatocellular Cancer.
Kensinger CD; Feurer ID; Karp SJ
Transplantation; 2017 Sep; 101(9):2056-2061. PubMed ID: 28471871
[TBL] [Abstract][Full Text] [Related]
74. Black Patients Have Unequal Access to Listing for Liver Transplantation in the United States.
Rosenblatt R; Wahid N; Halazun KJ; Kaplan A; Jesudian A; Lucero C; Lee J; Dove L; Fox A; Verna E; Samstein B; Fortune BE; Brown RS
Hepatology; 2021 Sep; 74(3):1523-1532. PubMed ID: 33779992
[TBL] [Abstract][Full Text] [Related]
75. The value of MELD and sodium in assessing potential liver transplant recipients in the United Kingdom.
Young AL; Rajagenashan R; Asthana S; Peters CJ; Toogood GJ; Davies MH; Lodge JP; Pollard SG; Prasad KR
Transpl Int; 2007 Apr; 20(4):331-7. PubMed ID: 17326773
[TBL] [Abstract][Full Text] [Related]
76. Geographic Disparity in Deceased Donor Liver Transplant Rates Following Share 35.
Bowring MG; Zhou S; Chow EKH; Massie AB; Segev DL; Gentry SE
Transplantation; 2019 Oct; 103(10):2113-2120. PubMed ID: 30801545
[TBL] [Abstract][Full Text] [Related]
77. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
[TBL] [Abstract][Full Text] [Related]
78. Assessing variation in the costs of care among patients awaiting liver transplantation.
Axelrod DA; Dzebisashvili N; Lentine K; Segev DL; Dickson R; Tuttle-Newhall E; Freeman R; Schnitzler M
Am J Transplant; 2014 Jan; 14(1):70-8. PubMed ID: 24165015
[TBL] [Abstract][Full Text] [Related]
79. ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption.
Barone M; Avolio AW; Di Leo A; Burra P; Francavilla A
Transplantation; 2008 Mar; 85(6):844-9. PubMed ID: 18360266
[TBL] [Abstract][Full Text] [Related]
80. Offer acceptance practices and geographic variability in allocation model for end-stage liver disease at transplant.
Wey A; Pyke J; Schladt DP; Gentry SE; Weaver T; Salkowski N; Kasiske BL; Israni AK; Snyder JJ
Liver Transpl; 2018 Apr; 24(4):478-487. PubMed ID: 29316203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
